Glucoraphanin (myrosinase-activated)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glucoraphanin (myrosinase-activated), covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND) [NA]